Horvat, T. Z., Adel, N. G., Dang, T., Momtaz, P., Postow, M. A., Callahan, M. K., . . . Chapman, P. B. (2015). Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center. Journal of clinical oncology, 33(28), 3193. https://doi.org/10.1200/JCO.2015.60.8448
Citácia podle Chicago (17th ed.)Horvat, Troy Z., et al. "Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center." Journal of Clinical Oncology 33, no. 28 (2015): 3193. https://doi.org/10.1200/JCO.2015.60.8448.
Citácia podľa MLA (8th ed.)Horvat, Troy Z., et al. "Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center." Journal of Clinical Oncology, vol. 33, no. 28, 2015, p. 3193, https://doi.org/10.1200/JCO.2015.60.8448.